Drug Discovery Today 2005-05-15

Keynote review: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists

Jos H.M. Lange, Chris G. Kruse

Index: Drug Discov. Today 10 , 693-702, (2005)

Full Text: HTML

Abstract

The proven clinical efficacy of the CB1 cannabinoid receptor antagonist rimonabant in obesity and its further therapeutic potential has given a tremendous impetus to the discovery of novel CB1 antagonists.

Related Compounds

Related Articles:

Synthesis, structure-activity relationship, and evaluation of SR141716 analogues: development of central cannabinoid receptor ligands with lower lipophilicity.

2003-02-13

[J. Med. Chem. 46 , 642-645, (2003)]

More Articles...